| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 60.61B | 58.42B | 55.85B | 52.10B | 48.04B | 44.03B |
| Gross Profit | 25.92B | 23.62B | 24.49B | 22.68B | 20.61B | 19.25B |
| EBITDA | 24.27B | 24.24B | 21.54B | 19.52B | 17.84B | 18.19B |
| Net Income | 6.38B | 6.05B | 5.55B | 5.03B | 4.09B | 6.24B |
Balance Sheet | ||||||
| Total Assets | 128.88B | 128.01B | 124.94B | 120.74B | 119.12B | 115.74B |
| Cash, Cash Equivalents and Short-Term Investments | 9.16B | 7.24B | 6.69B | 4.36B | 2.27B | 6.45B |
| Total Debt | 19.63B | 30.88B | 20.75B | 18.74B | 19.30B | 16.93B |
| Total Liabilities | 59.96B | 59.04B | 55.14B | 51.11B | 50.67B | 45.66B |
| Stockholders Equity | 68.65B | 68.69B | 69.73B | 69.57B | 68.40B | 70.01B |
Cash Flow | ||||||
| Free Cash Flow | 11.48B | 11.04B | 10.55B | 9.97B | 9.05B | 8.78B |
| Operating Cash Flow | 20.93B | 20.31B | 19.88B | 18.79B | 18.94B | 18.07B |
| Investing Cash Flow | -9.86B | -9.82B | -8.91B | -7.85B | -14.20B | -8.13B |
| Financing Cash Flow | -10.23B | -10.16B | -8.63B | -8.85B | -8.91B | -9.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $80.66B | 14.75 | 20.61% | 2.69% | 9.51% | 187.55% | |
70 Outperform | $22.28B | 26.59 | 9.28% | 5.03% | 10.34% | 17.26% | |
68 Neutral | $10.74B | 20.05 | 17.55% | 7.82% | 8.21% | 30.97% | |
64 Neutral | $16.28B | 51.19 | 12.76% | 6.14% | -6.44% | -27.87% | |
62 Neutral | $34.57B | ― | -0.79% | 3.77% | 16.69% | 87.12% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |